Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
FBIOP

Market Cap: $145.24M

FI

Fortress Biotech, Inc.

FBIOP

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin62.53%

EBITDA Margin2.33%

EBIT Margin2.26%

Pre-tax Margin2.13%

Net Profit Margin1.63%

Earnings Yield1.40%

Valuation Multiples

Price / Book0.49

Price / Sales1.22

Price / Earnings0.77

PEG0.00

Forward PEG-0.01

EV / Sales-0.70

EV / EBITDA-0.30

EV / Operating Cash Flow-0.38

EV / Free Cash Flow-0.38

Price / Free Cash Flow0.67

Price / Operating Cash Flow0.63

Cash Flow & Capital

Free Cash Flow / Share$3.97

Operating Cash Flow / Share$3.98

Free Cash Flow Yield1.50%

Capex / Revenue0.12%

Capex / Operating Cash Flow0.06%

Capex / Depreciation0.02

Stock Compensation / Revenue8.26%

Dividend Payout Ratio0.42%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio3.96

Quick Ratio3.83

Cash Ratio3.17

Debt / Assets0.20

Debt / Capital0.28

Debt / Equity0.39

Long-Term Debt / Capital0.22

Debt / Market Cap63.69%

Net Debt / EBITDA-0.82

Solvency Ratio1.06

Financial Leverage1.93

Efficiency & Working Capital

Asset Turnover0.22

Fixed Asset Turnover4.97

Inventory Turnover3.15

Receivables Turnover1.86

Payables Turnover2.16

Days Sales Outstanding195.93

Days Inventory Outstanding116.06

Days Payables Outstanding168.7

Operating Cycle311.98

Cash Conversion Cycle143.28

Working Capital Turnover0.36

Returns & Quality

Return on Equity1.04%

Return on Assets35.31%

Return on Invested Capital-10.85%

ROCE-11.52%

Return on Tangible Assets38.40%

Operating Return on Assets-8.71%

Income Quality1.11

Tax Burden0.77

Interest Burden0.94

Balance Sheet & Intrinsic Metrics

Enterprise Value$-48.08M

Invested Capital$222.77M

Working Capital$183.49M

Tangible Asset Value$180.58M

Net Current Asset Value$134.88M

Graham Number$20.29

Graham Net-Net$3.71

Book Value / Share$6.51

Tangible Book Value / Share$5.7

Cash / Share$6.21

Financial Health Scores

Piotroski Score5

Altman Z-Score-1.15

Revenue$67.57M

EBIT$-13.32M

Market Cap$150.44M

Working Capital$192.09M

Retained Earnings$-623.68M

Total Assets$356.87M

Total Liabilities$154.5M